104 results
8-K
EX-1.1
TPST
Tempest Therapeutics Inc
20 Jun 24
Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a Six-Month Improvement over Control Arm
8:13am
with the Commission or retention where required and legending, and each such Free Writing Prospectus, as of its issue date and at all subsequent
DEFA14A
excwcpl ob1i7y
26 May 22
Additional proxy soliciting materials
4:06pm
PRE 14A
zcf8wa sg1at50z1wr0
22 Apr 22
Preliminary proxy
4:01pm
8-K
EX-1.1
6envyc0
23 Jul 21
Other Events
5:20pm
8-K
EX-99.5
6kwqqy aadqcom55hoz4
16 Jul 21
Other Events
4:31pm
8-K
EX-99.2
bcdtqq5a4ldtg1yn7l7u
16 Jul 21
Other Events
4:31pm